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Abstract 
Background: Hailey-Hailey disease (familial 
benign chronic pemphigus) of the vulva is a rare 
autosomal dominant dermatosis characterized 
by malformation of desmosomes and bullae, 
particularly in intertriginous areas. 
Cases: We reviewed the cases of 5 women 
followed at a single academic institution over a 
period of 17 years. Of the 5 patients, 4 carried a 
diagnosis of Hailey-Hailey at the time of 
presentation to our institution, and one was 
diagnosed on biopsy. 3 were members of a 
family group. Initial treatment of choice was a 
topical steroid (betamethasone in 3, fluocinonide 
and hydrocortisone in 1 each), vulvar skin 
guidelines, tepid soaks, a skin protectant (A&D 
ointment, zinc oxide) and additional treatment 
(crotamiton in 1, clotrimazole in 2, and 
Polysporin in 1). Final treatment regimens in 3 
patients followed long term were zinc oxide/A&D 
and betamethasone-clotrimazole ointment in all 
3, nystatin-triamcinolone ointment in 2, oral 
minocycline in 1, oral fluconazole prn in 1, and 
topical tacrolimus in 1. Treatment courses were 
complicated by superimposed fungal infections, 
superimposed bacterial infections, and lichen 
simplex chronicus flares. These were treated 
with antifungals, topical clindamycin and 
metronidazole, and steroid-antifungal bursts, 
respectively. Three of five patients followed long 
term achieved successful remission with 
occasional flares. 
Discussion: Treatment of Hailey-Hailey disease 
must be tailored to the individual patient. 
Adherence to vulvar skin care guidelines is 
critical for the remission of Hailey-Hailey 
disease. Treatment is long-term and may be 
complicated by episodes of fungal and bacterial 
superinfection and lichen simplex chronicus. 
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Background 
Hailey-Hailey disease (HHD) (familial 
benign chronic pemphigus) is a rare 
autosomal dominant intraepidermal 
blistering disorder first described by the 
Hailey brothers in 1939.1 Onset is in the 
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3rd to 4th decade and affects males and 
females equally. Family history is 
positive in 70% of cases.2 
HHD lesions are characterized as 
recurrent, small blisters and crusted 
erosions on an erythematous base with 
a predilection for friction areas (nape of 
neck, axillae, submammary regions, 
genitocrural, perianal, and intergluteal 
clefts, antecubital and popliteal fossae3). 
Solitary involvement of the vulva is 
rare.4 The lesions are first described as 
blisters, which then turn to thickened red 
plaques with linear fissures that can 
exhibit crusting, scaling, and 
hypertrophic growths.3 The disease has 
also been described to clinically present 
as leukoplakia, condyloma, lichenified 
white papules, or syringoma.4 The 
symptoms are worsened by increased 
sweating/moisture in the summer and 
obesity.5 Approximately 70% of patients 
also have longitudinal white bands 
present in fingernails.6   
Diagnosis is indicated by chronicity of 
lesions, resistance to treatment, 
presence of similar lesions in other 
areas (nape of neck, axillae), presence 
of longitudinal white bands in the 
fingernails, and a positive family 
history.7  
HHD is due to a mutation in the ATP2C1 
gene on chromosome 3, which codes 
for a calcium pump of the Golgi 
apparatus in keratinocytes. This 
mutation causes loss of intraepidermal 
coherence and breakdown of 
intercellular contacts between the 
desmosomal proteins and 
tonofilaments.8,9 Histologic specimen 
often shows dyskeratotic cells with 
acantholysis that lack epidermal 
hyperplasia or hyperkeratosis.7  
The differential diagnosis of Hailey-
Hailey Disease includes tinea cruris, 
eczema, psoriasis, candidiasis, herpes 
simplex virus, atopic dermatitis, lichen 
simplex, seborrheic dermatitis, Darier's 
disease, pemphigus, and carcinoma of 
the vulva.10,11,12 
Treatment options from a review of the 
literature are varied and include 
methods of moisture reduction 
(antiperspirant, weight loss, gauze pads, 
powder), antibiotics, antifungal creams, 
steroids (oral, topical, or injection), 
botulinum toxin injections, tacrolimus, 
retinoids, dapsone, methotrexate, and 
topical 5-Fluorouracil cream.5,6,10,13,14 
More invasive treatment options include 
carbon dioxide laser therapy, 
photodynamic therapy, dermabrasion, 
excision, and split thickness skin 
grafting.6,15 These modes of treatment 
require several weeks to months of 
painful healing, but in some cases have 
been shown to provide definitive 
resolution of symptoms.  
In this report we detail the cases of 5 
women with Hailey-Hailey disease of the 
vulva and the varied treatment regimens  
successful in their care. 
Cases  
Patient 1: A 47 y.o presented to the 
Vulvar-Vaginal Disease (VVD) clinic with 
a previous diagnosis of Hailey-Hailey 
disease and a positive family history. 
She endorsed burning with urination and 
constant vulvar itching. On physical 
exam she had erythema, 
hyperkeratosis, and skin changes 
consistent with HHD on the vulva, groin, 
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and mons pubis (Figure 1). Initial 
treatment was vulvar skin care 
guidelines, Zeasorb® powder (Stiefel 
Laboratories, Inc. North Caroline), A&D 
ointment, crotamiton cream, and topical 
betamethasone. Flares were controlled 
with oral doxycycline and clobetasol 
cream. Complications included vaginal 
yeast infections treated with oral 
fluconazole and econazole cream, as 
well as secondary bacterial infections 
treated with doxycycline. She preferred 
to see her local physician due to travel 
time and was lost to follow up.  
 
Figure 1: HHD affected skin of the 
vulva, mons pubis, and groin of 
Patient 1. 
Patient 2: A 39 y.o presented to the 
VVD clinic for evaluation of suspected 
condyloma. On exam she had a raised, 
hyperpigmented, hyperkeratotic plaque 
with mild erosions and a macerated 
appearance around the border on her 
perineum. She also had plaques on the 
sides of her neck with erosions and 
hyperkeratosis. She reported the lesions 
had been present since age 13 and her 
father had similar skin changes in the 
same distribution. A punch biopsy was 
taken of the perineal lesion and showed 
acantholysis and dyskeratosis 
consistent with HHD. Initial treatment 
consisted of vulvar skin care guidelines, 
topical clindamycin lotion, and oral 
doxycycline. Complications included 
secondary yeast infections treated with 
fluconazole. Patient preferred to follow 
with dermatology, who recommended 
hydrocortisone ointment and Polysporin. 
She ultimately passed away due to 
unrelated causes. 
Patient 3: A 30 y.o presented to the 
VVD clinic with a preexisting diagnosis 
of HHD. She had two sisters (patients 4 
and 5 in this study) who also suffered 
from the disease. She endorsed 
significant rectal itching. Physical exam 
showed skin changes consistent with 
HHD in the perianal region. Initial 
therapy included vulvar skin care 
guidelines, A&D ointment, tepid soaks, 
and betamethasone-clotrimazole cream. 
She achieved good control after 1 
month of this regimen and thereafter 
only used the steroid cream for flares 
that occurred 1 week prior to each 
menstrual period. Complications of her 
disease course included lichen simplex 
chronicus flares. She achieved excellent 
and long lasting control with a final 
treatment regimen consisting of 
betamethasone-clotrimazole cream and 
nystatin-triamcinolone ointment only 
used during flares, as well as zinc oxide 
ointment, tepid soaks, and strict vulvar 
skin care guidelines.  
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Patient 4: A 35 y.o (sister of patients 3 
and 5) presented to the VVD clinic with 
a preexisting diagnosis of HHD. She 
complained of itching, burning with 
urination, pain with walking and 
intercourse, and thick, white discharge. 
Physical exam showed erythema and 
severe hyperkeratosis in the vulvar area 
with patches of lichen simplex chronicus 
and changes consistent with HHD. Initial 
treatment consisted of tepid soaks, A&D 
ointment, vulvar skin care guidelines, 
and topical fluocinonide ointment. She 
also had a few axillary lesions, treated 
with topical metronidazole. Use of the 
fluocinonide was ultimately discontinued 
due to development of a rash. She 
instead trialed oral doxycycline and 
topical clindamycin cream for 
exacerbations. She still had residual 
itching with this regimen, and so tried 
multiple different topical treatments 
including nystatin-triamcinolone 
ointment, hydrocortisone valerate 
ointment, betamethasone-clotrimazole 
cream, and tacrolimus 0.1% ointment. 
Complications during her disease 
course included vaginal yeast infections 
treated with fluconazole, and axillary 
striae from chronic steroid use. Her final 
treatment regimen consisted of oral 
minocycline and topical betamethasone-
clotrimazole cream for flares plus topical 
tacrolimus 0.1% ointment for 
maintenance therapy. This regimen 
provided excellent control of her HHD. 
Patient 5: A 37 y.o (sister of patients 3 
and 4) presented to the VVD clinic with 
a preexisting diagnosis of HHD. She 
complained of daily burning, itching, and 
pain in the vulvar and perianal area, as 
well as thick yellow/green vaginal 
discharge. She had axillary and vulvar 
lesions consistent with HHD (Figures 2 
and 3). 
 
Figure 2: HHD lesion left inner thigh 
pre-treatment Patient 5 
 
Figure 3: Lesion in left inner thigh 
post treatment Patient 5 
Her initial treatment consisted of vulvar 
skin care guidelines, A&D ointment, 
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tepid soaks, and topical betamethasone-
clotrimazole. She continued to have 
residual symptomatic flares, so nystatin-
triamcinolone cream was added and 
different steroid ointments were trialed, 
including triamcinolone, hydrocortisone-
pramoxine ointment, fluocinonide 
ointment, clobetasol, betamethasone-
clotrimazole cream and betamethasone 
valerate ointment. She also received 
cortisol injections in the axillary regions 
resulting in good control of axillary 
disease. Complications included a 
clitoral abscess, which was drained and 
treated with bacitracin ointment, 
abnormal vaginal flora treated with 
clindamycin vaginal cream, vaginal 
yeast infections treated with nystatin-
triamcinolone ointment and oral 
fluconazole, and exacerbations of lichen 
simplex chronicus. Her final treatment 
regimen consisted of betamethasone-
clotrimazole cream for HHD 
exacerbations, nystatin-triamcinolone 
ointment plus fluconazole for intermittent 
vaginal yeast infections, vulvar skin care 
guidelines, and zinc oxide cream. 
Discussion 
The cases presented detail the varied 
treatments of Hailey-Hailey disease in 5 
different individuals (See Table 1). 
Treatment goals for the 5 patients were 
symptom remission as well as 
minimization of social and functional 
handicaps. 
Table 1 
Patient Preexisting  
Diagnosis 
Initial Steroid Final Steroid Additional Treatment 
1 HHD Betamethasone N/A Crotamiton, 
oral doxycycline,  
fluconazole 
2 Condyloma Hydrocortisone N/A Topical clindamycin, 
polysporin oral doxycycline, 
fluconazole 
3 HHD betamethasone-
clotrimazole 
betamethasone-
clotrimazole 
Nystatin/ triamcinolone 
4 HHD fluocinonide betamethasone-
clotrimazole 
Oral minocycline,  
topical tacrolimus 
5 HHD betamethasone-
clotrimazole 
betamethasone-
clotrimazole 
Nystatin/ triamcinolone,  
oral fluconazole prn 
 
Some aspects of treatment were similar 
for all 5 patients, most notable being the 
need for skin protection and adherence 
to strict vulvar skin care guidelines to 
minimize friction, heat, and moisture, as 
these can induce flares. However, many 
aspects of the treatment had to be 
tailored to the individual patient. Use of 
steroid differed between individuals 
depending on potency required to 
adequately manage disease flares, and 
use of antibiotics also depended on 
clinical symptoms of the patient. This is 
a trend that has been reported in the 
literature. In a retrospective study of 58 
individuals with Hailey-Hailey disease, 
86% found topical steroid/antibiotic 
combinations to be effective at 
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managing the disease.16 However, 
multiple potencies were used among 
different patients ranging from milder 
(hydrocortisone) to ultra potent 
(clobetasol) preparations, with 2 patients 
requiring oral prednisone. Only 43% 
used oral antibiotics and found them 
helpful.16 These results mirror the 
variability in treatment found among our 
patients. 
Complications of Hailey-Hailey Disease 
experienced by our patients included 
episodes of superimposed fungal and 
bacterial infections as well as lichen 
simplex chronicus flares. These were 
treated with antifungals, topical 
clindamycin and metronidazole, oral 
doxycycline or minocycline, and steroid-
antifungal bursts. Another complication 
is the rare occurrence of squamous cell 
carcinoma in Hailey-Hailey affected 
skin,17,18,19 which was not experienced 
by any of our 5 patients. These 
complications, and the relapsing and 
remitting nature of the disease, underlie 
the importance of regular follow up. 
One new treatment option for Hailey-
Hailey disease that has been increasing 
in popularity is the chemo-denervation 
of sweat glands by regional injection of 
botulinum toxin to decrease sweat, 
moisture, and friction in affected areas. 
Multiple case reports have shown 
complete remission expected to last 6-
12 months with multiple doses of 
botulinum toxin type A.20,21 This 
treatment option is attractive because it 
decreases the use of systemic and 
topical corticosteroids and minimizes 
their respective side effect profiles. 
However, it was not feasible for our 
patients due to high cost and lack of 
insurance coverage. 
Conclusion 
Treatment of Hailey-Hailey disease 
must be tailored to the individual patient. 
Adherence to vulvar skin care guidelines 
is critical for the remission of Hailey-
Hailey disease. Treatment is long-term 
and may be complicated by episodes of 
fungal and bacterial superinfection and 
lichen simplex chronicus. 
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